Drug intelligence / Profile preview

Rhinase Baby

Development stage: Unknown
Lead developer: Profounda
Modality: Small Molecules
Administration: Intranasal

Overview

**Rhinase Baby** is a nonprescription intranasal lubricating nasal-drop product developed by Profounda for newborns, infants, and toddlers with nasal dryness and associated congestion. It is described as containing dual salts and dual wetting agents that moisturize nasal passages, dilute and mobilize mucus toward the front of the nose, and facilitate removal with an aspirator or tissue; it does not have a defined receptor-mediated pharmacologic target. ([prnewswire.com](https://www.prnewswire.com/news-releases/profounda-inc-launches-rhinase-baby-lubricating-nasal-drops-the-only-non-prescription-wetting-agent-based-nasal-moisturizer-that-will-help-babies-and-toddlers-with-nasal-dryness-associated-with-allergies-low-humidity-stuffy-300586765.html))

Brand names: Rhinase BabyRhinase Baby Lubricating Nasal Drops

Beyond the preview

Go deeper on Rhinase Baby.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhinase Baby.

Explore the full profile